Ledger.Open graph →
SEC Form D · Amendment · filed April 10, 2020

Prometheus Biosciences, Inc

Offering
$60.0M
Sold
$48.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Mike Walther · SAN DIEGO, CAExecShlomo Melmed · SAN DIEGO, CADirectorLauren Otsuki · SAN DIEGO, CAExecMark Mckenna · SAN DIEGO, CAExec · DirectorDouglas Wall · SAN DIEGO, CADirectorLaurens Kruidenier, Ph.D · SAN DIEGO, CAExecAllison Luo, M.D · SAN DIEGO, CAExecWilliam Sandborn, M.D · SAN DIEGO, CADirectorGregory Behar · SAN DIEGO, CADirectorChris Slavinsky · SAN DIEGO, CAExecShierley Widjaja · SAN DIEGO, CADirectorMark Stenhouse · SAN DIEGO, CADirectorJames Laur · SAN DIEGO, CADirectorTadataka Yamada, M.D · Seattle, WADirectorThierry Dervieux, Pharm D., Ph.D · SAN DIEGO, CAExecGregory Behar · SAN DIEGO, CADirectorMike Walther · SAN DIEGO, CAExecShlomo Melmed · SAN DIEGO, CADirectorLauren Otsuki · SAN DIEGO, CAExecMark Mckenna · BROOMFIELD, COExec · DirectorDouglas Wall · VISTA, CADirectorChris Slavinsky · SAN DIEGO, CAExecLaurens Kruidenier, Ph.D · SAN DIEGO, CAExecShierley Widjaja · SAN DIEGO, CADirectorAllison Luo, M.D · SAN DIEGO, CAExecMark Stenhouse · SAN DIEGO, CADirectorWilliam Sandborn, M.D · SAN DIEGO, CADirectorJames Laur · SAN DIEGO, CADirectorTadataka Yamada, M.D · Seattle, WADirectorThierry Dervieux, Pharm D., Ph.D · SAN DIEGO, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗